Henry Schein, Inc. (NASDAQ:HSIC) Expected to Post FY2025 Earnings of $5.56 Per Share

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Leerink Partnrs cut their FY2025 earnings per share estimates for Henry Schein in a research note issued on Tuesday, May 7th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $5.56 per share for the year, down from their previous estimate of $5.63. Leerink Partnrs has a “Market Perform” rating on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $5.07 per share. Leerink Partnrs also issued estimates for Henry Schein’s FY2026 earnings at $6.06 EPS and FY2027 earnings at $6.61 EPS.

A number of other brokerages have also recently issued reports on HSIC. Barrington Research boosted their target price on Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday. TheStreet raised shares of Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. Evercore ISI increased their price target on Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a report on Wednesday, February 28th. JPMorgan Chase & Co. upped their target price on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. Finally, Piper Sandler raised their target price on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a report on Monday, February 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $81.73.

Henry Schein Trading Up 2.2 %

Shares of HSIC opened at $72.76 on Thursday. Henry Schein has a twelve month low of $60.01 and a twelve month high of $82.63. The firm has a market capitalization of $9.35 billion, a P/E ratio of 23.10, a price-to-earnings-growth ratio of 1.68 and a beta of 0.87. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. The stock’s fifty day simple moving average is $73.01 and its 200 day simple moving average is $72.34.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.09. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The company’s revenue was up 3.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.21 EPS.

Institutional Investors Weigh In On Henry Schein

Hedge funds have recently made changes to their positions in the business. McGlone Suttner Wealth Management Inc. bought a new stake in Henry Schein during the 4th quarter valued at $39,000. Neo Ivy Capital Management bought a new stake in shares of Henry Schein during the third quarter valued at about $46,000. Mather Group LLC. acquired a new stake in Henry Schein in the first quarter worth about $97,000. Covestor Ltd increased its stake in Henry Schein by 22.8% during the 3rd quarter. Covestor Ltd now owns 1,367 shares of the company’s stock valued at $102,000 after buying an additional 254 shares during the period. Finally, Palisade Asset Management LLC bought a new stake in shares of Henry Schein during the 1st quarter worth about $113,000. Institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In other news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.